Citation Impact
Citing Papers
MYC on the Path to Cancer
2012 Standout
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
2011
Osteosarcoma treatment: state of the art
2009
Cancer drug resistance: an evolving paradigm
2013 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma
2011
Outcome for adolescent and young adult patients with osteosarcoma
2012
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Validation of an extension of the international non‐invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis
2010
Primary bone osteosarcoma in the pediatric age: State of the art
2006
Effects of COVID-19-Related School Closures on Student Achievement-A Systematic Review
2021 Standout
Recent Advances in Neuroblastoma
2010
Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma
2012
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2020 Standout
Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
2011
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Impact of the COVID-19 Pandemic on Online Consumer Purchasing Behavior
2021 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
2013
Fluctuating Attitudes and Behaviors of Customers toward Online Shopping in Times of Emergency: The Case of Kuwait during the COVID-19 Pandemic
2021
Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
2021
Natural product and natural product derived drugs in clinical trials
2014 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Impact of the COVID‐19 pandemic on children with and without risk for neurodevelopmental impairments
2021
2016
Promising Therapeutic Targets in Neuroblastoma
2012
Works of Marta Podda being referenced
Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
2009
A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma
2003
Prolonged 14‐day continuous infusion of high‐dose ifosfamide with an external portable pump: Feasibility and efficacy in refractory pediatric sarcoma
2010
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
2012
How young patients with cancer perceive the COVID‐19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears?
2020
Immunomodulation in a Treatment Program Including Pre- and Post-Operative Interleukin-2 and Chemotherapy for Childhood Osteosarcoma
2003
Soft Tissue Sarcomas of Childhood and Adolescence: The Prognostic Role of Tumor Size in Relation to Patient Body Size
2008
Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection.
2001